Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment clinical trial (NCT02711813). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from TAB08?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment clinical trial (NCT02711813). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment clinical trial (NCT02711813). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment clinical trial (NCT02711813). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment clinical trial (NCT02711813). Contact the study team or your healthcare provider for specific answers.

What this study is about